Leiter JRS, Upadhaya R, Anderson JE. Nitric oxide and voluntary exercise together promote quadriceps hypertrophy and increase vascular density in female 18-mo-old mice. Am J Physiol Cell Physiol 302: C1306 -C1315, 2012. First published February 8, 2012 doi:10.1152/ajpcell.00305.2011.-Age-related sarcopenia reduces the size, strength, and function of muscle, and the diameter of muscle fibers. It also disrupts the dystrophin-glycoprotein complex, dislocating nitric oxide synthase 1 (NOS-1) and reducing sarcolemmal integrity. This study of quadriceps muscle in 18-mo-old mice showed that NO-donor treatment with isosorbide dinitrate (I) for 6 wk, in combination with voluntary exercise for 3 wk, increased muscle mass by 25% and stimulated cell proliferation. The resulting fiber hypertrophy was accompanied by a lower ratio of protein:DNA, consistent with myogenic-cell hyperplasia. Treatment enhanced the ratio of NOS-1:␤-dystroglycan in correlation with fiber diameter, improved sarcolemmal integrity, and increased vascular density after an increase in vascular endothelial growth factor protein at 3 wk. Results demonstrate that age-related muscle refractoriness to exercise can be overcome with NO-donor treatment. Since activation of muscle stem cells and vascular perfusion are limiting factors in the maintenance, regeneration, and growth of aged muscle, results suggest the feasibility of using NO-donor drugs to combat atrophy and muscle ischemia. Improved function and quality of life from the NO-amplified effects of exercise may be useful in aging and other conditions such as disuse, insulin resistance, or microgravity. sarcopenia; satellite cells; nitric oxide donor; beta-dystroglycan; VEGF AGE-RELATED MUSCLE ATROPHY in humans is arguably inevitable, since 100% of older individuals experience some degree of sarcopenia (32). Muscle wasting results from atrophy of individual fibers, loss and expansion of motor units (24, 37, 79) that becomes increasingly severe from late-middle age to senescence in both fast-and slow-twitch muscles (63) and ultimately weakness limits function and quality of life. Current treatments, such as exercise and growth-promoting drugs, are not completely effective, in part as we do not fully understand the many facets of age-related atrophy.
hepatocyte growth factor and the c-met receptor (3, 73, 83) , drugs that increase the NO concentration have potential to promote growth in old muscle. Research using a whole muscle culture system showed that the age-related reductions in muscle-specific neuronal nitric oxide synthase (NOS-1) concentration and activity are reversed by treatment with a NO-donor drug, one that releases NO without activity of NOS (43) . Similarly, in old rats, NOS protein levels in muscle decrease with aging and increase after exercise training (68) . In culture, the effectiveness of stretch to activate SC increases when coupled with NO-donor treatment (43) , but application of NO-donor compounds with exercise to treat age-related atrophy in vivo is not yet tested.
The dystrophin-glycoprotein complex (DGC) connects sarcomeres across the sarcolemma to the extracellular matrix (66) . It has a critical role in sensing and responding to mechanical forces imposed on the sarcolemma (55) . In normal muscle, NOS-1 is anchored in the DGC in an optimal position for communication with satellite cells (3) . Diffusion of NO from the fiber either maintains SC quiescence or activates SCs, depending on the amount of NO produced (81, 82) . Aged and dystrophic muscle have an abnormal response to loading compared with young, healthy muscle (53, 58) . Defects in the DGC (62) and subsequent dislocation of NOS-1 (71) at least partly explain deficits in mechanochemical signaling that normally induce SC activation. During aging, muscle also displays reduced perfusion (76) while exercise stimulates angiogenesis via increases in vascular endothelial growth factor (VEGF), which in turn simulates NO production by NOS-3 (42, 77) . Interestingly, angiogenesis is related to both VEGF and NO signaling, and is marked by production of VEGF (40) by endothelial and satellite cells (61) . Both types of cells respond to NO and make NOS-1 and NOS-3 proteins (in different relative amounts), and endothelial cells produce endothelin-1, which inhibits NO-dependent vasodilation (74) . As well, the vascular proliferative response to increased VEGF in electrically stimulated muscle contraction is NO dependent through NOS-1 in muscle fibers and NOS-3 in endothelial cells (51) . Changes in perfusion and the DGC with increasing age would be exacerbated by changes in capillary density and SC responsiveness to NO and mechanical signals, and ultimately reduce the capacity for maintenance, growth, and repair of muscle as age increases.
We investigated the effects of a NO-donor drug, isosorbide dinitrate (ISDN), and exercise, separately and in combination, on muscle mass and fiber size in sarcopenic muscle by studying cell proliferation, NOS-1 and ␤-dystroglycan (␤DG) in the DGC, fiber integrity, vascular density, and the level of VEGF protein. The hypothesis was that NO-donor treatment com-bined with exercise would promote growth of muscle in 18-mo-old female mice in vivo.
MATERIALS AND METHODS
Animals and experimental design. Female C57BL/6 mice [bred or maintained from Jackson Laboratory stock (Bar Harbor, MA)] were housed at the Animal Holding Facility until 18 mo of age (mo) on a 12:12-h light:dark cycle, as approved by the Protocol Management and Review Committee at our institution in accordance with the Canadian Council on Animal Care. Between 18 and 19.5 mo, sarcopenia is established (Leiter and Anderson, unpublished observations) and comorbidities are much less pronounced for this strain than they would be in senescent mice at 24 -37 mo. Mice were randomly assigned to one of four groups with or without treatment with isosorbide dinitrate (I) and/or exercise, as follows. Daily oral treatment with I (66 mg/kg in canola oil, po) started at the beginning of the experiment and continued for 6 wk. Half the mice had access to a voluntary running wheel for voluntary exercise (Ex) for the first 3 wk of the treatment period, as reported (5) . A previous study showed quadriceps from 18-mo mice were refractory to hypertrophy following 3 wk of voluntary exercise, whereas younger 8-mo mice were responsive (44) ; this experiment tested whether NO-donor treatment could change the responsiveness to exercise and induce muscle growth in the 18-mo group. Groups were control (C, oil only, n ϭ 6), Ex (n ϭ 8), I (n ϭ 4), and I ϩ Ex (n ϭ 3). At the end of 6 wk, mice were injected with tritiated thymidine ( 3 H-tdr: 1 Ci/g body wt ip) and euthanized 2 h later by cervical dislocation under isoflurane anesthesia (Baxter, Mississauga, ON).
Tissues. The quadriceps, gastrocnemius (GAST), and tibialis anterior (TA) muscles were dissected and weighed; mass was normalized to body mass. Muscles were cut in half across the muscle belly, and halves were either placed in Eppendorf tubes (Westbury, NY) and snap frozen in liquid nitrogen and stored at Ϫ80°C until extraction of DNA or protein, or embedded in optimal cutting medium, frozen in an isopentane slurry, and cryosectioned.
Fiber diameter. Sections (7 m, 50 m apart) were stained with hematoxylin and eosin (H&E; Fisher, NJ) and photographed using an Olympus BH-2 microscope (at ϫ100). Using NIH-Image J software, fiber diameter was measured along the shortest diameter (Ն600 fibers per group). Mean (and SE) and frequency distribution of diameter were compared among groups.
Cell proliferation. Frozen muscle was weighed, minced over dry ice, placed in lysing matrix-A tubes (MP Biomedicals, Solon, OH), and homogenized in DNA extraction solution (1 M NH 4OH; 0.2% Triton X-100) at a speed of 4.0 m/s for 40 s using a FastPrep-24 (MP Biomedicals, Solon, OH). After 10 min incubation at 37°C, 600 l of homogenate was mixed with 300 l of 2 M acetic acid, mixed gently by inversion, and centrifuged at 14,000 relative centrifugal force (rcf) at 4°C for 5 s. Supernatant was transferred to new vials; one aliquot was used to determine the DNA concentration with a Hoeschst dye assay using a Victor microplate reader (Perkin Elmer, Waltham MA). A second aliquot was transferred to scintillation vials containing 5 ml of Scinti-Safe (Fisher Scientific, Ottawa, ON) to count disintegrations per minute (dpm) over a 15-min period using an LS 6500 scintillation counter (Beckman-Coulter, Mississauga, ON). Cell proliferation was represented as disintegrations per minute per microgram DNA (dpm/g DNA) as previously reported (4, 5 ] at a 1:5,000 dilution for 1 h at room temperature. Bands were visualized using chemiluminescence according to the manufacturer (Santa Cruz Biotechnology, sc-2048). The optical density of bands (OD minus background) was measured using NIH-Image J software and normalized to actin.
Immunostaining. Double immunostaining for NOS-1 and ␤DG was performed using the IHC World protocol, which is a parallel approach (31) that employs multiple blocking steps including normal goat serum, the unconjugated Fab fragment of goat anti-rabbit or antimouse IgG, and avidin and biotin as reported (52) . After blocking, sections were incubated in a mixture of two primary antibodies, rabbit polyclonal anti-NOS1 (sc-1025, Santa Cruz Biotechnology, 1:50) and mouse monoclonal anti-␤-dystroglycan (NCL-43DAG, Novocastra, 1:100) overnight at 4°C. After washing in Tris-buffered saline with Tween (TBST, 0.5 M Tris base and 9% NaCl in water with 0.5% Tween 20) sections were incubated with a mixture of two secondary antibodies (AMCA-conjugated Fab fragment goat anti-rabbit, and DyLight 649-conjugated Fab fragment goat anti-mouse, Jackson ImmunoResearch Laboratories, West Grove, PA, 1:200) for 1 h. After washing in TBST, sections were mounted under coverslips using Vectashield (Vector Laboratories, Burlingame, CA). Omission of primary antibody served as a negative control. Sections were viewed without knowledge of source group.
Sarcolemmal integrity. Since ␤DG forms an essential core of the DGC that links the internal cytoskeleton across the membrane to the extracellular matrix (27) , we examined the age-related reduction in ␤DG in relation to functional changes that increase fiber permeability to serum proteins such as IgG. Immunostaining for mouse IgG was performed as follows. Briefly, sections were incubated for 1 h in blocking solution (10% goat serum in phosphate-buffered saline and 2 M glycine, 20:1), rinsed, and incubated with goat antibody to mouse IgG (DyLight 649-conjugated Fab fragment, Jackson ImmunoResearch Laboratories, 1:200) for 1 h. After washing in TBST, sections were mounted under coverslips. Fluorescence was viewed using an Axio Imager Z1 equipped with AxioVision Rel.4.7 software (Carl Zeiss Canada, Toronto, ON). All imaging parameters were kept constant between samples, viewed without knowledge of source group.
Histochemistry. Nonspecific alkaline phosphatase (AP) histochemistry was used to visualize vascular endothelial cells in quadriceps muscle cryosections. The reaction provided substrate (5-Br-4-Cl-3-indoxyl phosphate, Sigma) dissolved in a solution of dimethylformamide and tetranitroblue tetrazolium salt (Sigma) in 1 ml of 0.1 M Tris HCl, pH 9.4, according to a standard method (8) . Vascular density was assessed using the Weibel-Gomez method, viewing three random fields of transversely cut fibers in each section (avoiding areas of muscle-tendon junctions) through a 10 ϫ 10 ocular grid at 200ϫ magnification (29, 70, 78) . The mean (number per field) of AP-stained vessel profiles intersecting grid lines was counted on slides coded to minimize observer bias. Counts were reproducible with Ͻ8% variation among five repeat counts on a test section.
Statistical analysis. Values are expressed as means Ϯ SE. Groups were compared by analysis of variance (ANOVA) followed by post hoc Tukey's HSD means-comparison or Chi-squared tests (for frequency distribution), as appropriate using Excel 2007 and SAS (JMP). A probability of P Յ 0.05 indicated statistical significance.
RESULTS
Muscle mass and fiber diameter. Quadriceps mass increased ϳ25% after treatment with I ϩ Ex compared with the control group ( Table 1 , P Ͻ 0.01). The mass of tibialis anterior and gastrocnemius muscles did not change with treatment (Table  1) . Fiber diameter in the quadriceps also increased in the I ϩ Ex group (P Ͻ 0.05) and was reduced by exercise alone (P ϭ 0.05) compared with C (Fig. 1) . The distribution of fiber diameter was shifted to larger fibers in the I ϩ Ex group compared with both C and Ex groups (P Ͻ 0.01, Chi-squared). There was no difference in distance run over a 24-h period between the two exercised groups (distance ranged from 2,649 Ϯ 911 m/24 h to 4,230 Ϯ 1,512 m/24 h) during the 3-wk course of exercise.
Cell proliferation and protein:DNA ratio. Cell proliferation, assessed by incorporation of 3 H-tdr into DNA, was lower after Ex compared with all other groups (P Ͻ 0.05, Fig. 2 ). Proliferation increased after I compared with the control group (P Ͻ 0.01). The I ϩ Ex group showed greater proliferation in quadriceps than C and Ex groups (P Ͻ 0.01) and was ϳ30% higher than in the I group. The overall ratio of total protein to total DNA in muscle homogenates was less in groups receiving ISDN (I and I ϩ Ex) compared with those without (C and Ex) (P Ͻ 0.01, Fig. 3 ). Although the cell types responsible for proliferation were not identified, there was no apparent infiltration by immune cells or change in the level of inflammation apparent among muscles of the different groups.
Proteins. NOS-1 concentration (relative to actin) was higher in muscle from all old groups (19.5 mo) compared with quadriceps from 6-wk-old young mice (P Ͻ 0.01, Fig. 4A ). NOS-1 in old mice did not change after any treatment, although NOS-1 tended toward an increase after I treatment compared with the C group (P ϭ 0.08). The concentration of ␤DG (relative to actin) was also unchanged with treatment (Fig. 4B) . However, the ratio of NOS-1:␤DG was increased by in the I group compared with all other groups (P Ͻ 0.05). The NOS-1:␤DG ratio was also higher at 19.5 mo (all 4 groups) than at 6 wk (P Ͻ 0.05, Fig. 4C ). The NOS-1:␤DG ratio was significantly correlated to fiber diameter (P Ͻ 0.01, R 2 ϭ 0.26, Fig. 4E ). The levels of Pax7 and MyoD proteins did not change with treatment. However, the NOS-1:␤DG ratio was correlated to the level of Pax7 protein (P Ͻ 0.001, R 2 ϭ 0.57, Fig. 4F ). Immunostaining of NOS-1 and ␤-dystroglycan. Immunostaining studies of NOS-1 and ␤DG localization in quadriceps Values are means Ϯ SE of muscle mass in mg. C, control; Ex, exercised; I, treated with isosorbide dinitrate; I ϩ Ex, treated with isosorbide dinitrate plus exercise. *Significant difference (P Ͻ 0.01). fibers ( Fig. 5) showed striking changes between 19.5 mo groups compared with muscle from young mice. In 6 wk mice, immunoreactivity for NOS-1 and ␤DG was a uniformly smooth outline around fibers. In quadriceps from older C mice, staining for anti-␤DG staining was discontinuous, almost punctate, around fibers and in some locations was completely absent. In the same sections, NOS-1 staining was more generalized throughout the cytoplasm compared with the peripheral outline around fibers in muscle from young mice. After I ϩ Ex treatment, muscle fibers displayed NOS-1 and ␤DG proteins that were similar to the profile in young muscle. Staining was more evenly distributed around fibers compared with staining in C muscle, although some fibers had discontinuous segments of ␤DG, resembling "beads." Immunostaining was absent in negative-control slides.
Sarcolemmal integrity evaluated by IgG staining. Immunoreactivity for serum IgG protein was not observed in the cytoplasm of quadriceps fibers from young mice (Fig. 6A) . By contrast, in quadriceps from 19.5-mo controls, many fibers showed cytoplasm with intense labeling for IgG. Fibers with the internal profile of cytoplasmic IgG immunostaining were much less frequent in the I ϩ Ex group compared with C group. Quadriceps fibers in the Ex group showed the same staining pattern as in the C group.
Vascular density and VEGF. Vascular endothelium was visualized using AP histochemistry and vessel profiles quantified by counting intersections per field on a Weibel grid. Vessel profiles were observed more frequently in quadriceps sections from I ϩ Ex-treated animals ( Fig. 7A ) and vascular density was nearly twofold higher in I ϩ Ex than C or Ex groups (P Ͻ 0.01) (Fig. 7B) . Although the level of 41-kDa VEGF protein (relative to actin) did not differ among groups after 6 wk treatment (Fig. 7, C and D) , quadriceps muscle from a subset of I and I ϩ Ex groups (n ϭ 3-4) euthanized after 3-wk treatment (i.e., tissues collected at the end of the exercise period) showed a threefold increase in VEGF compared with all four groups after 6-wk treatment (P Ͻ 0.001).
DISCUSSION
This study in old mice examined whether treatment with a NO-donor drug, ISDN, for 6 wk would improve the impact of 3 wk of voluntary exercise starting at 18 mo. NO-donor Fig. 3 . Total protein-to-DNA ratio in quadriceps muscle. Mice treated with ISDN (I group) and ISDN ϩ EX (I ϩ Ex) had decreased protein-to-DNA ratio compared with the C group and Ex group. Bars with one or more different letters are significantly different (P Ͻ 0.01).
Fig. 4. NOS-1 and ␤-dystroglycan in quadriceps.
A: isosorbide dinitrate (I) tended to increase nitric oxide synthase-1 (NOS-1) protein content (P ϭ 0.08). B: there were no significant changes in ␤-dystroglycan protein content compared with the control and other groups. The I group showed the greatest increase in NOS-1:␤-dystroglycan ratio (C). Data represent means Ϯ SE. Bars with one or more different letters were significantly different. D: representative Western blots. The NOS-1:␤-dystroglycan ratio was significantly correlated to fiber diameter (E; P Ͻ 0.01) and the level of Pax7 protein relative to actin protein (F; P Ͻ 0.001). Y, young (6-wk-old) mice. treatment stimulated exercise-induced muscle growth by a functionally important 25% increase in mass. Hypertrophy was accompanied by modifications in the DGC, particularly the ratio and localization of NOS-1 and ␤DG ratio. As well, the same muscles showed increased vascular density and a reduced influx of serum IgG into fibers. Muscle mass, fiber diameter, and cell proliferation in quadriceps muscle increased after combined treatment with I ϩ Ex compared with age-matched controls. The response was muscle-specific and restricted to quadriceps, as noted in an earlier study in 8-mo-old mice. Exercise alone in younger mice induced an increase in fiber cross-sectional area and NOS-1 protein, and reduced the growth inhibitor, myostatin (38, 44, 49, 50, 67) . By contrast, in older mice in the present study, I ϩ Ex also partially restored the normally close association of NOS-1 and ␤DG in the DGC, and increased the prevalence of NOS-1 at the fiber membrane. Notably, the correlation of fiber diameter and the NOS-1:␤DG ratio accompanied by a decrease in anti-IgG staining in fibers suggested that cytoskeletal integrity was stabilized by NOdonor treatment, which should be investigated as underpinning the growth response to exercise. The increase in vascular density after 6 wk I ϩ Ex treatment followed an earlier increase in VEGF protein after 3 wk. While not conclusive as to mechanism, collectively, findings illustrate NO acts as a potent adjuvant to exercise in inducing fiber growth. NO-donor treatment during a relatively short intervention of voluntary exercise was efficacious in producing hypertrophy by sarcopenic muscle in old mice, muscle that typically resists exercise-induced growth (44, 68) . Results have strong potential for application to improve quality of life through prevention and treatment of age-related atrophy, since strength and muscle mass are so strongly correlated (12, 30) . Notably, only longerterm voluntary exercise was previously noted to induce hypertrophy in old mice (10, 80) .
Exercise alone in 18-mo female mice decreased quadriceps fiber diameter (44) . Since only combined I ϩ Ex treatment induced fiber growth by effects on proliferation, the cytoskeleton, and vascularity, muscle hypertrophy was likely dependent on a combination of effects on sarcolemmal stability, SC activation, the mechanobiology of exercise, and perfusion. SC activation by stretching is typically perturbed beyond 6 mo; this leads to SC becoming increasingly refractory to mechanical stimuli (stretch, exercise, strain) with increasing age. This was demonstrated by experiments using cultures of single fibers (7) and whole muscles (43) , and by in vivo experiments (44) . Although the measure of cell proliferation in this study included SC and other cell types in the assay for [ 3 H]thymidine uptake, the notable hypertrophy in context of the decreased protein:DNA ratio in quadriceps after I treatment (Ϯ exercise) indicates myogenic cells contributed to the proliferating population that supported fiber growth. Similar contribution from myonuclear addition during hypertrophy was required for muscle growth following exercise or endurance training (6, 45, 57) . NO-donor treatment in vivo and L-arginine treatment in whole muscle cultures from old mice (43) both show that exogenous NO can overcome the age-related disruption of NO-dependent SC activation by exercise. In the present study, that bypass of SC refractoriness produced fiber hypertrophy in a powerful fast-twitch muscle. We therefore propose that combining exercise with an exogenous source of NO has potential as a method to combat age-related muscle atrophy. NO donors improved regeneration in mdx mouse diaphragm during prednisone treatment (52) and effects of nonsteroidal anti-inflammatory drugs on mdx mouse dystrophy and alpha-sarcoglycanopathy (11, 64) . By extension, therefore, since SC activation is a critical step in muscle regeneration, NO-based interventions very likely have strong potential to rescue the regenerative capacity of stem cells in aged muscle.
The impact of exercise and ISDN treatment to induce hypertrophy was restricted to the quadriceps muscle in this study. Although fiber type-independent responses are known (14) , the specific features of exercise that impact particular muscles and fiber types are an important aspect of adaptative muscle function in relation to training and levels of NOS (68), physiology of recruitment and loading (69) , dislocation response to unloading from suspension (71) , and muscle loading in voluntary exercise (41, 77) . Additional differences in muscle architecture, the configuration of fiber insertion, developmental fibertype patterns, and the functional angle of applied tension in lengthening and shortening contractions also impact the range of phenotypic responses resulting from aging and interventions in vivo (44) . Indeed, the gait cycle of voluntary exercise, including alternating plantar flexion/hip extension with hip flexion/knee extension, would have distinctive functional demands on particular muscles, depending on changes in pennation and fiber shortening with age, and including need for stabilization by co-contraction around the knee. Identifying the source of muscle-specific effects of exercise is thus limited by lack of metabolic information such as exercise effects on maximal oxygen consumption (V O 2max ), cytochrome oxidase, citrate synthase or other components of the Krebs cycle in muscles that increased after 16 wk wheel running in oxidative muscles of young female mice (19) . Therefore, muscle-specific changes, such as hypertrophy from wheel running, were not unexpected. However, it is interesting that responses to exercise were most apparent in the quadriceps in this study and in dystrophinopathy (5) .
The level of NOS-1 protein is generally accepted to be stable during aging in adult muscle, and we previously reported that quadriceps muscle NOS-1 did not change from 8 to 18 mo in mice (44) , consistent with a study in rat plantaris between 2 and 22 mo of age (7) . However, the current study found NOS-1 relative to actin in quadriceps increased between 6 wk and 19.5 mo, and increased in response to exercise and/or NO-donor treatment. A similar response to exercise was reported for gastrocnemius and soleus muscles of 24-mo rats (68) . Variations may relate to muscle-or species-specific changes during aging and/or use of different loading controls [actin (here and Ref. 7) vs. GAPDH (44, 68) ]. Supposedly stable "housekeeping" genes are noted to vary in relation to activity (13, 33) or fiber type (46) , since metabolism, the cell cycle, contractility, vascular perfusion, and disease state all impact the plastic interactions of function on structural compartments. Notably, the GAPDH promoter has 3 insulin-response elements in its promoter and responds to metabolic changes (2, 54) . Levels of GAPDH protein also decrease as a result of transcriptional modification in fast-glycolytic muscles of senescent rats compared with slow-twitch muscles (46) . Given that muscle fiber diameter was increased by combined I ϩ Ex treatment vs. I alone, reporting changes in protein concentration relative to actin would actually be a conservative estimate of those changes, since the level of actin protein itself in blots did not change across treatments (arbitrary OD units, means Ϯ SD: C 9,485 Ϯ 3,308; Ex 8,303 Ϯ 2,016; I 7,050 Ϯ 3,384; I ϩ Ex 9,364 Ϯ 1,975) whereas levels of GAPDH protein did change (means Ϯ SD: C 17,941 Ϯ 1,894; Ex 18,342 Ϯ 3,051; I 8,335 Ϯ 4,111; I ϩ Ex 14,440 Ϯ 6,930). A recent review eloquently demonstrated site-specific production and effects of NO in various tissues in the body, including skeletal muscle, lung, central nervous system, and liver (75) . The altered level of NOS-I in old muscle may be related to the compartmentalized environment within a particular muscle, and the location of the protein in fibers (internalized in the sarcoplasm vs. localized with the DGC).
There were intriguing relationships between the NOS-1: ␤DG ratio, the pattern of localization of the two proteins, and sarcolemmal integrity with fiber diameter. The NOS-1:␤DG ratio in quadriceps at 19.5 mo increased after ISDN treatment, with or without exercise. Here, study of the ratio of two proteins (probed on two halves of the same blot), both typically localized within the dystroglycan complex, obviates the need for an additional loading control. Immunostaining studies showed that the age-related disruption of NOS-1 and ␤DG localization was restored by I ϩ Ex toward a more even pattern of distribution at the fiber periphery, as observed in youngadult muscle. Secondary age-related changes in transmembrane signaling (60) by MAPK phosphorylation (62) and NO release from NOS-1 (71) would each be counteracted by normalizing the localization of the two DGC proteins. A physiological improvement in sarcolemmal integrity was shown by the decrease in IgG that had penetrated fibers after I ϩ Ex treatment compared with old controls. Such sarcolemmal disruption was observed previously in 36-mo rat muscle, and increased further under tension (62) , a feature that is reminiscent of DGC disruption and membrane leakiness (47) of muscle in old animals and in muscular dystrophies (58) . As well, during hindlimb suspension, there is displacement of NOS-1 into the sarcoplasm that is reported to induce atrophy via apoptosis (71) . Together the present results on DGC proteins and sarcolemmal integrity strongly suggest that an increase in the NOS-1:␤-DG ratio produced after I ϩ Ex treatment may be important in preventing fiber damage in aged muscle by reducing membrane leakiness, secondarily reducing low-grade inflammation in aged muscle (56) , and reducing the activity of apoptotic pathways leading to atrophy. Notably, DGC integrity and NOS-1 localization are essential in the normal regulation of satellite cell activation during regeneration and muscle growth (3, 59) , and loss of membrane integrity raises susceptibility to contraction-induced injury and reduces regeneration in aged muscle (1, 9, 21, 23, 47, 48) . Complex interactions between aging, DGC proteins, fiber integrity, muscle atrophy, and muscle growth and regeneration likely underlie the remarkable hypertrophy of quadriceps muscle that was observed after treatment with voluntary exercise plus the NOdonor drug, ISDN. The significant correlations between the NOS-1:␤DG ratio, relative Pax7 levels and muscle fiber size, and changes in the protein:DNA ratio provide suggestive evidence of these interactions, although changes in DGC proteins may be unrelated to the hypertrophic response to exercise as neither the protein levels or the NOS-1:␤DG ratio tended to normalize after treatment toward the levels seen in muscle from younger 6 wk mice. However, results do indicate that the reduced capacity of aged muscle to grow in response to exercise can be significantly reversed through NO-donor treatment, and that the treatment response included partial restoration of sarcolemmal integrity and changes in the DGC.
Exercise induces angiogenesis and vascular remodeling through a complex regulatory cascade involving VEGF (including VEGF alternative splicing, dimerization, and receptor interactions), NO-related vascular permeability and prostaglandins, matrix metalloproteinases, and Wnt, Notch, and fibroblast growth factor signals (16, 20, 22, 25, 39) . Notably, capillary density declines with age (26) . In 12-mo-old rats, L-arginine treatment alone increased blood vessel density with only a marginal increase in soleus mass relative to body weight after 6 wk of endurance training (fiber size was not measured) (70) . Interestingly, capillary density (8) and exercise-induced angiogenesis are also muscle-or fiber-type specific (77) . In relation to human studies, voluntary wheel running is more similar to interval training, whereas strenuous treadmill exercise in rodents is similar to endurance training in humans (discussed in Refs. 44, 48a, 74a) , although the extent of running suggests relatively intense training during the 3 wk of exercise. In rats, voluntary wheel running has resulted in muscle hypertrophy up to 27 mo in the soleus and up to 10 mo in the plantaris (10; 37a). Wheel running induced muscle hypertrophy in young mice at 8 mo (44) and 8 wk (45) and increased cell proliferation and NOS-I protein levels while reducing the level of myostatin in muscle. The interactive relationship between NOS-1 and VEGF signaling and the possibility that they combine to mediate exercise-related hypertrophy during NOdonor treatment in older mice (18 -19.5 mo) is intriguing. Both myogenic satellite cells and endothelial cells in skeletal muscle tissue produce NO and VEGF, respond to NO, and express both NOS-1 and NOS-3, and VEGF signaling is NO dependent (51, 61) . Such interactions, and possible differential changes between males and females with increasing age, related to estrogen interaction with NOS-3 and VEGF in cardiac and cerebral angiogenesis (34, 35) , require further investigation.
The timing of the increase in VEGF protein followed by increased vascular density and a decline in VEGF in this study is consistent with the early and later effects of muscle activity on angiogenesis that are VEGF dependent and independent, respectively (28) . Increased capillary density would be anticipated to increase perfusion, which in turn could attenuate the partial denervation phenotype that develops in aging muscles (24) . Although the basis of increased cell proliferation is not identified in this study, hypertrophy in young mice induced by voluntary exercise was critically dependent on satellite cell proliferation, which suggests at least a contribution by SCs to fiber diameter hypertrophy in older mice. Therefore, while the precise basis of quadriceps fiber hypertrophy in older female mice treated with a NO donor and exercise has yet to be elucidated, the outcomes of SC activation, angiogenesis, dystroglycan-NOS-1 stabilization, and membrane integrity suggest NO donors may ultimately find application to boost the impact of moderate exercise in combating age-related muscle atrophy.
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